Privigen Alternatives Compared
| Privigen (immune globulin intravenous) | Nplate (romiplostim) | Doptelet (avatrombopag) |
|
|---|
| Privigen (immune globulin intravenous) | Nplate (romiplostim) | Doptelet (avatrombopag) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Immune Thrombocytopenia. Privigen may also be used for purposes not listed in this medication guide. View more |
Prescription only
Nplate may be used to increase platelet counts above 50 x 109/L in adults and children with ITP who have not had a good response to corticosteroids, immunoglobulins, or removal of their... View more |
Prescription only
Doptelet may be used to increase the level of platelets in the blood, in patients with chronic liver disease scheduled to undergo a procedure. It is started 10 to 13 days before the procedure and... View more |
Related suggestions Immune Thrombocytopenia
|
|||||||||||||||||||||||
| More about Privigen (immune globulin intravenous) | More about Nplate (romiplostim) | More about Doptelet (avatrombopag) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Privigen has an average rating of 7.8 out of 10 from a total of 9 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 11% reported a negative effect. |
Nplate has an average rating of 7.5 out of 10 from a total of 11 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 9% reported a negative effect. |
Doptelet has an average rating of 7.9 out of 10 from a total of 9 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 11% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Privigen side effects |
View all Nplate side effects |
View all Doptelet side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Privigen prices |
View all Nplate prices |
View all Doptelet prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other immune globulin intravenous brands include: Alyglo, Asceniv, Bivigam, Carimune NF, Flebogamma, Gammagard S/D, Gammaplex, Octagam, Panzyga, Yimmugo View more |
N/A |
Other avatrombopag brands include: Doptelet Sprinkle | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
576 hours |
816 hours |
19 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 107 drugs are known to interact with Privigen:
|
A total of 10 drugs are known to interact with Nplate:
|
A total of 88 drugs are known to interact with Doptelet:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
August 22, 2008 |
May 21, 2018 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.